EW vs RSSS · P/E 47, rev $1.39B vs P/E 15, rev $49.1M
Edwards Lifesciences Corp (EW) versus Research Solutions Inc (RSSS) — a side-by-side from cached financials, not a winner call.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Research Solutions Inc (RSSS) is a software - application company listed on NASDAQ.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Latest reported RSSS revenue for 2025-06-30 was $49.1M. Net income was $1.3M. Revenue was up 9.9% from 2024-06-30 to 2025-06-30. RSSS currently screens at market cap $74.9M and trailing P/E 14.9.
EW currently screens at market cap $49.91B and trailing P/E 46.9. RSSS currently screens at market cap $74.9M and trailing P/E 14.9.
Not investment advice. Open the EW and RSSS stock pages for the full models.
Not investment advice.